Interlaboratory concordance of DNA sequence analysis to detect reverse transcriptase mutations in HIV-1 proviral DNA. ACTG Sequencing Working Group. AIDS Clinical Trials Group.
about
Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis.TREAT Asia Quality Assessment Scheme (TAQAS) to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratoriesGenotypic testing for human immunodeficiency virus type 1 drug resistance.Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase.Monitoring resistance to human immunodeficiency virus type 1 protease inhibitors by pyrosequencing.Human immunodeficiency virus type 1 drug resistance testing: a comparison of three sequence-based methods.Quality assessment program for genotypic antiretroviral testing improves detection of drug resistance mutations.Sources and magnitude of intralaboratory variability in a sequence-based genotypic assay for human immunodeficiency virus type 1 drug resistance.A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.Update on the laboratory diagnosis and monitoring of HIV infection.High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patientsSequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assayClinical and analytical relevance of NNRTIs minority mutations on viral failure in HIV-1 infected patients.
P2860
Q33592278-87B743A7-1810-43E6-9D59-1CBDA4B8E0EDQ33824827-258EFB2D-4C36-444E-BA92-BFB7DCCF780CQ33906239-69F44315-9353-4F04-A72A-071E2D430011Q33961507-94364996-3693-4D11-B1DA-2B03BD76E17FQ33971117-358D13E7-869D-412A-A869-61CE0EF655F7Q33972550-A4CAF273-B887-4B6B-89A4-DF27812B3CA7Q34746064-760EF43B-FC43-4242-A825-6CBB2EE5069BQ35156231-4A381327-4934-4020-81D0-7F8477410B50Q35742512-1C0E8E25-31A7-4D31-AAF3-1039986D78F9Q36342049-7678977D-349A-4CB4-9A04-B22319121C06Q39464193-6E817FEC-0A59-49D3-A8F5-5675F9304911Q40909665-C0F76812-0FD0-476F-B6A1-EFA9BBF23C13Q42254682-4D5D2E02-2B4C-44A5-921D-DDF40146E2BE
P2860
Interlaboratory concordance of DNA sequence analysis to detect reverse transcriptase mutations in HIV-1 proviral DNA. ACTG Sequencing Working Group. AIDS Clinical Trials Group.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Interlaboratory concordance of ...... p. AIDS Clinical Trials Group.
@en
Interlaboratory concordance of ...... p. AIDS Clinical Trials Group.
@nl
type
label
Interlaboratory concordance of ...... p. AIDS Clinical Trials Group.
@en
Interlaboratory concordance of ...... p. AIDS Clinical Trials Group.
@nl
prefLabel
Interlaboratory concordance of ...... p. AIDS Clinical Trials Group.
@en
Interlaboratory concordance of ...... p. AIDS Clinical Trials Group.
@nl
P2093
P1476
Interlaboratory concordance of ...... up. AIDS Clinical Trials Group
@en
P2093
D Kuritzkes
J Fitzgibbon
K Sannerud
P304
P356
10.1016/S0166-0934(98)00100-1
P577
1998-11-01T00:00:00Z